Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer

Clinical trial NCT06289751 · RECRUITING

Trial details

NCT number: NCT06289751
Sponsor: Tongji Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Cancer Neoadjuvant Chemoimmunotherapy Radical Hysterectomy Extrafascial Hysterectomy

Start date: 2024-09-03
Primary completion: 2026-03-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.